Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth

por Zhang, Yizheng, Zhang, Chuchu, Li, Jiehan, Jiang, Meimei, Guo, Shuning, Yang, Ge, Zhang, Lingling, Wang, Feng, Yi, Shiqi, Wang, Jiangang, Fu, Yang, Zhang, Yingjie
Publicado 2022

Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway

por Liu, Nannan, Jiang, Xinxiu, Guo, Leiming, Zhang, Chuchu, Jiang, Meimei, Sun, Zhuoran, Zhang, Yizheng, Mi, Wunan, Li, Jiehan, Fu, Yang, Wang, Feng, Zhang, Lingling, Zhang, Yingjie
Publicado 2022

Targeting ERK induced cell death and p53/ROS-dependent protective autophagy in colorectal cancer

por Mi, Wunan, Wang, Chuyue, Luo, Guang, Li, Jiehan, Zhang, Yizheng, Jiang, Meimei, Zhang, Chuchu, Liu, Nannan, Jiang, Xinxiu, Yang, Ge, Zhang, Lingling, Zhang, Ge, Zhang, Yingjie, Fu, Yang
Publicado 2021